Codexis Inc (CDXS) financials

NASDAQ · Health Care

$1.19 -2.46% Close Oct 30, 2026 Live

Codexis revenue and earnings by year

Codexis's revenue was $70.4 million in the fiscal year to December 31, 2025, up 18.6% from the year before. Net income was -$44.0 million, -62.5% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 4.1% a year on average.

RevenueNet income
$0$100M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue7059701391056968615049
Revenue growth18.6%-15.4%-49.4%32.3%51.7%0.9%13.0%21.1%2.4%—
Gross profit614357101835553483639
Gross margin86.7%72.6%81.7%72.6%78.8%80.1%77.2%79.2%71.4%80.0%
Operating income-42-59-68-35-23-24-13-11-23-9
Operating margin-59.3%-98.6%-97.0%-25.2%-21.7%-34.6%-18.3%-18.6%-45.9%-17.5%
Net income-44-65-76-34-21-24-12-11-23-9
Net margin-62.5%-110.0%-108.7%-24.2%-20.3%-34.8%-17.4%-18.0%-46.0%-17.5%
Diluted EPS-$0.50-$0.89-$1.12-$0.51-$0.33-$0.40-$0.21-$0.22-$0.49-$0.22
Free cash flow-24-54-563-28-20-16-17-10-3

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CDXS in Markets.

How Codexis makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Product$13.2M88.6%
Research & Development Revenue$1.70M11.4%

See also: CDXS returns

No forecast, no recommendation. This page describes Codexis Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.